A Study to Evaluate the Pharmacokinetic Interaction and the Safety of AD-236A and AD-236B
Clinical trial NCT07730567 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07730567
- Sponsor
- Addpharma Inc.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-29
- Primary completion
- 2026-09-13
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.